Table 4.
Characteristics | Responsive group | Unresponsive group |
---|---|---|
Symptom score | 1.8 ± 0.6∗ | 5.9 ± 2.4 |
Medication score | 2.8 ± 1.1∗ | 5.6 ± 1.8 |
Total score | 4.7 ± 1.7∗ | 10.5 ± 3.3 |
IL-36γ (pg/mL) | 377.5 ± 159.1∗ | 838.1 ± 347.8 |
IL-5 (pg/mL) | 9.6 ± 4.8∗ | 24.1 ± 9.3 |
IL-13 (pg/mL) | 68.2 ± 23.9∗ | 273.4 ± 81.6 |
Proportion of ILC2 (%) | 0.02 ± 0.01∗ | 0.14 ± 0.04 |
Abbreviations: IL-5, interleukin-5; IL-13, interleukin-13; IL-36γ, interleukin-36γ; ILC2, IL-36γ on group II lymphoid cell.
∗ Compared with baseline, P < 0.05.